SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.050-3.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenneth shopsin who wrote (323)4/12/1999 1:18:00 AM
From: Kramer   of 441
 
RE/delist/ Surely you jest!! LOL You must have mistaken this for the ktel message board. Neog has a rock solid balance sheet with $10 million in cash and virtually no debt. Just because reuters had a headline that read "net off" on the last earnings report the stock trades off as people head for the hills? Well the "net off" for those of us that know was only a very shallow analysis of the quarter. Once again the reporters get it wrong by comparing the two quarters without taking into account the change in taxable environment. The quarters income really showed growth of almost 50% over last year. IMHO the only possible thing one could complain about was the 15% revenue growth for the quarter, but then again the third quarter isn't necessarily neog's strongest, but 25% sofar this year isn't bad. BTW, usually neog's 1st quarter is the strongest. Smart money going into neog at these levels.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext